Group items matching

in title, tags, annotations or url

As "The Army's Sensor Developer," NVESD researches and develops cutting edge technology, with the goal of exceeding U.S. Soldier requirements, and allowing an asymmetrical advantage in changing battlefield environments. This BAA solicits proposals against a broad range of night vision technologies which support the Warfighter and challenges of Asymmetric Warfare. The technologies have been divided into three (3) sections: Science and technology; Ground Combat Systems; and Modeling and Simulation.

NIST is soliciting applications for financial assistance for Fiscal Year 2016 (FY16) within the following NIST Laboratory grant programs: (1) the Material Measurement Laboratory (MML) Grant Program; (2) the Physical Measurement Laboratory (PML) Grant Program; (3) the Engineering Laboratory (EL) Grant Program; (4) the Fire Research (FR) Grant Program; (5) the Information Technology Laboratory (ITL) Grant Program; (6) the Communications Technology Laboratory (CTL) Grant Program; (7) the NIST Center for Neutron Research (NCNR) Grant Program; (8) the Center for Nanoscale Science and Technology (CNST) Grant Program; (9) the Special Programs Office (SPO) Grant Program; (10) the Standards Coordination Office (SCO) Grant Program; (11) the International and Academic Affairs Office (IAAO) Grant Program; and (12) the Associate Director for Laboratory Programs (ADLP) Grant Program.

NIST is soliciting applications for financial assistance for Fiscal Year 2016 (FY16) within the following NIST Laboratory grant programs: (1) the Material Measurement Laboratory (MML) Grant Program; (2) the Physical Measurement Laboratory (PML) Grant Program; (3) the Engineering Laboratory (EL) Grant Program; (4) the Fire Research (FR) Grant Program; (5) the Information Technology Laboratory (ITL) Grant Program; (6) the Communications Technology Laboratory (CTL) Grant Program; (7) the NIST Center for Neutron Research (NCNR) Grant Program; (8) the Center for Nanoscale Science and Technology (CNST) Grant Program; (9) the Special Programs Office (SPO) Grant Program; (10) the Standards Coordination Office (SCO) Grant Program; (11) the International and Academic Affairs Office (IAAO) Grant Program; and (12) the Associate Director for Laboratory Programs (ADLP) Grant Program.

The Technology Validation and Start-Up Fund (the "Program") provides grants to transition Technology from Ohio research institutions into the marketplace through Ohio start-up companies. Ohio research institutions may apply for funding for validation (e.g. viability testing, prototyping, etc.) of their unlicensed technologies. Ohio start-up companies may apply for funding to advance towards commercialization a Technology they intend to license from an Ohio research institution.

This Funding Opportunity Announcement (FOA) seeks grant applications to catalyze major advances in genomics through technology development (beyond developing nucleic acid sequencing technologies). The goal is to provide a mechanism for support of very novel and high impact work from across this gamut of genomics technology development. This initiative seeks to support technologies that will have a major impact in the next five to seven years.

WHO CAN APPLY? I-Corps@Ohio funds will be offered on a competitive basis to teams of faculty researchers and graduate students developing institution-based technologies from Ohio colleges and universities. Under the supervision of business and entrepreneurial mentors, teams will develop market-driven value propositions and scalable business models around their technologies and attract follow on funding to support company formation and market entry. APPLICATION PROCESS The I-Corps@Ohio proposal submission process consists of five steps: 1. mandatory meeting with the appropriate TTO representative(s) at the PI's institution; 2. team selection of technology track (science and engineering or medtech); 3. registration of all team members in the online portal; 4. proposal submission; and 5. full team interview with I-Corps@Ohio program representatives. All teams are required to complete the online profile and submission questionnaire beginning October 23, 2019. Deadline to apply is January 15, 2019. The PI may complete this information or designate another member of the team as the lead member. Subsequent members of the team will be invited to join by the lead member through the application portal and must complete his or her profile. Every effort should be made to identify all team members prior to submitting the online proposal submission questionnaire. Additional team members may be added later. You will be asked to select from two tracks: Medtech Track: Teams will select Medtech Track if the subject technology is in the form of medical devices, diagnostics, medicines, vaccines, software, testing procedures and systems and is developed to solve a health/clinical problem and improve the quality of human life. Science and Engineering (S&E) Track: Teams will select S&E Track if the technology does not fit into the Medtech category.

To continue to strengthen the innovation ecosystem, NSF is revising NSF 12-511 to promote two choices under the Partnerships for Innovation (PFI): Accelerating Innovation Research (AIR) subprogram.  The first choice, Technology Translation, encourages the translation of technologically-promising research discoveries made by prior and/or current NSF-funded investigators toward a path of commercialization; while the second choice, Research Alliance, promotes synergistic collaborations between an existing NSF-funded research alliance (including consortia such as Engineering Research Centers, Industry University Cooperative Research Centers, Science and Technology Centers, Nanoscale Science and Engineering Centers, Materials Research Science and Engineering Centers, Centers for Chemical Innovation, and Emerging Frontiers in Research and Innovation grantees) and other public and private entities to motivate the translation and transfer of research discoveries into innovative technologies and commercial reality.  Both of these choices are designed to accelerate innovation that results in the creation of new wealth and the building of strong local, regional, and national economies.

A global automobile parts manufacturer, a client of NineSigma, believes credible air cleaning technology is key to comfortable automobile experience; particularly deodorization and sterilization technology will become increasingly important. The Client has promoted research and development on their own, however they now face a challenge to find a suitable solution to ensure both deodorization/sterilization and safety in a short time. Given that technological development of such air cleaning is done globally, the Client decided to find a partner to further accelerate the development speed, which lead to this offering.

Complete information, including the Request for Information (RFI), can be found on the EERE Exchange website - https://eere-exchange.energy.gov. Through this Request for Information (RFI), the United States Department of Energy (DOE) Office of Energy Efficiency and Renewable Energy (EERE), Water Power Technologies Office (WPTO) seeks input on new research to maximize the value of hydropower's contribution to grid resiliency and reliability today and into the future. This strategy includes pumped storage and traditional hydropower, and covers both new technology design as well as modeling and analysis to assess the range of value streams hydropower provides in the current and future power grid. This research will build targeted insight into economic, policy and technological barriers, inform future hydropower technology development, and improve the tools by which investment and operational decisions are made. WPTO seeks concise feedback from all relevant stakeholders. Responses to this RFI must be submitted electronically to WPTORFI@ee.doe.gov no later than 5:00pm (ET) on April 6, 2018. Responses must be provided as attachments to an email. Complete information, including the RFI, can be found on the EERE Exchange website - https://eere-exchange.energy.gov.

The purpose of this funding opportunity announcement (FOA) is to support non-commercial lab-to-user dissemination of novel, reliable imaging and bioengineering technologies, including devices, software, methods, chemical agents, etc. Proposed technologies should have been prototyped, validated, and are potentially highly impactful to the research community. However, their beyond-the-lab dissemination via commercialization or industry partnership is not anticipated. Projects should focus on transforming functioning prototypes to usable tools and delivering them to end users for high-quality research in a reliable manner. Related activities may include, but are not limited to, quality control, scale-up production, user training, and technical improvements that are within the scope of the prototyped technology and limited to applying proven techniques or existing resources. Projects that involve clinical trials, commercialization, academic-industry partnership, or service using existing equipment are not responsive to this FOA.

he purpose of this program is to investigate and evaluate advanced fuels and fuel technologies, fuel system component development, advanced combustor and augmentor designs, advanced fuel properties measurements, fuel system component development and safety and combustion emissions along with their integration into advanced aerospace applications and advanced technologies to prevent and mitigate fuel biodeterioration. Research will be performed to characterize and develop advanced fuels- and combustion-related technologies for use at all operating conditions in current and advanced weapons systems. 

The NIH Blueprint for Neuroscience Research is a collaborative framework through which 14 NIH Institutes, Centers and Offices jointly support neuroscience-related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders. This Funding Opportunity Announcement (FOA) will solicit research projects to facilitate the development and translation of tools and technology for non-invasive imaging and profiling of human central nervous system (CNS, including retina) small blood and lymphatic vessels; to investigate their role in CNS physiology, disease, repair processes, and responses to therapy using novel approaches. Applications can be focused on the development of new technology and tools, novel target or biomarker identification and validation studies, or a combination of mechanistic and technology development studies specific to human CNS small blood and lymphatic vessels in health and disease, across the life span.

Understanding the dynamic activity of neural circuits is central to the NIH BRAIN Initiative. This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for largescale recording and manipulation of neural activity to enable transformative understanding of dynamic signaling in the nervous system. In particular, we seek exceptionally creative approaches to address major challenges associated with recording and manipulating neural activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high-risk, but if successful could profoundly change the course of neuroscience research. Proposed technologies should be compatible with experiments in behaving animals, and should include advancements that enable or reduce major barriers to hypothesis-driven experiments. Technologies may engage diverse types of signaling beyond neuronal electrical activity for large-scale analysis, and may utilize any modality such as optical, electrical, magnetic, acoustic or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. Where appropriate, applications are expected to integrate appropriate domains of expertise, including biological, chemical and physical sciences, engineering, computational modeling and statistical analysis.

OBJECTIVE: This is an AF Special Topic partnership, please see the above AF Special Topic instructions for further details. A Phase I award will be completed over 3 months with a maximum award of $25K and a Phase II may be awarded for a maximum period of 12 months DESCRIPTION: Academia is producing disruptive science and technology innovations at an increasingly rapid pace. Hence, rather than utilizing a pre-defined requirements approach, this topic is intended to be an open call for ideas and technologies that may not be currently listed (i.e. the unknown-unknown) under STTR topics, but nonetheless still fit within broad interest areas of the Air Force basic research level. These broad areas (Engineering and Complex Systems, Information and Networks, Physical Sciences, and Chemistry/Biological Sciences) are covered in greater detail at wpafb.af.mil/Welcome/Fact-Sheets/Display/Article/842026. To be eligible, offeror(s) must be teams that have formed companies and partnered with a university (e.g. university entrepreneurship centers, university technology transfer offices). The offeror should demonstrate their technical capability by demonstrating a credible and high-potential minimum viable product (MVP) along with a credible plan for developing the prototype to a commercially available solution. This topic is not looking for fully formed products, and it is acceptable if the solutions are earlier stage.

This funding opportunity announcement (FOA) supports efforts to disseminate resources and to integrate them into neuroscience research practice. Projects should be highly relevant to specific goals of the BRAIN Initiative, goals that are described in the planning document "BRAIN 2025: A Scientific Vision." They should engage in one or more of the following activities: distribution of tools and reagents; user training on the usage of new technologies or techniques; providing access to existing technology platforms and specialized facilities; minor improvements to increase the scale/efficiency of resource production and delivery; minor adaptations to meet the needs of a user community. Applications strictly focused on technology or software development, rather than dissemination of an existing resource, are not responsive to this FOA. Refinements to microscopes or tools necessary to customize them to the experimental needs of the end users are allowed. Projects should address compelling needs of neuroscience researchers working toward the goals of the BRAIN 2025 report that are otherwise unavailable or impractical in their current form.

This Funding Opportunity Announcement (FOA) invites exploratory/developmental applications that propose transformative engineering solutions to technical challenges associated with meaningful development, substantial optimization of existing technologies and clinical translation of intraoral biodevices. Proposed technologies are expected to advance development of oral biodevices to clinical use, including but not limited to: precision medicine-based detection, diagnosis and treatment of oral and overall health conditions, and measurement of patient functional status and clinical outcome assessment. Areas of interest in this FOA include engineering approaches that allow integration of electronic, physical, and biological systems essential to the development of functional biodevices that are safe and effective for detection, diagnosis and treatment of oral and systemic disease. Products of this research will be proof-of-concept prototype biodevices, dedicated biosensors and associated core technologies that enable development of safe and effective intra-oral biodevices intended for specific clinical applications. To streamline the development of oral biodevices that advance precision medicine-based approaches in clinical practice, this FOA encourages interdisciplinary collaborations across engineering, multifunctional sensors, pharmacology, chemistry, medicine, and dentistry, as well as between academia and industry.

The Collegiate Inventors Competition recognizes student inventors whose research and inventions will change our future.   The Competition promotes exploration in invention, science, engineering, technology, and other creative endeavors and provides a window on the technologies from which society will benefit in the future. Entries are judged on the originality and inventiveness of the new idea, process, or technology. The entry must be complete, workable, and well articulated. Entries are also judged on their potential value to society (socially, environmentally, and economically), and on the scope of use.   Students must be enrolled (or have been enrolled) full-time in any U.S. college or university at least part of the 12-month period prior to the date the entry is submitted. In the case of a team (maximum of four students), at least one member of the team must meet the full-time eligibility criteria. The other team members must have been enrolled on a part-time basis (at a minimum) sometime during the 12-month period prior to the date the entry is submitted.

The Biotechnology, Biochemical, and Biomass Engineering (BBBE) program supports fundamental engineering research that advances the understanding of cellular and biomolecular processes (in vivo, in vitro, and/or ex vivo) and eventually leads to the development of enabling technology and/or applications in support of the biopharmaceutical, biotechnology, and bioenergy industries, or with applications in health or the environment.  Quantitative assessments of bioprocesses are considered vital to successful research projects in the BBBE program.  Fundamental to many research projects in this area is the understanding of how biomolecules and cells interact in their environment, and how those molecular level interactions lead to changes in structure, function, phenotype, and/or behavior.  The program encourages proposals that address emerging research areas and technologies that effectively integrate knowledge and practices from different disciplines, and effectively incorporate ongoing research into educational activities. Research projects of particular interest in BBBE include, but are not limited to: Metabolic engineering and synthetic biology Quantitative systems biotechnology Tissue engineering and stem cell culture technologies Protein engineering/protein design Development of novel "omics" tools for biotechnology applications

Applicants must choose one of the following categories they feel their project best exemplifies: 1.) Outstanding Emerging Innovation: The winning nominee is a person or company working on the basic research phase of an innovation - for three years or less, pre-commercialization - that has received grant money or outside money and that demonstrates the potential for continued growth and success. 2.) Outstanding Bioscience Innovation: The winning nominee is a company that has achieved a significant milestone in the life sciences, including but not limited to drug therapeutics, medical devices, medical imaging and pharmacogenetics. 3.) Outstanding Information Technology Innovation: The winning nominee is a company that has achieved a significant milestone in information Technology, including hardware and software, packaged applications, custom applications and digital media. 4.) Outstanding Marketing Innovation: The winning nominee is a company that has achieved a significant milestone in consumer marketing. 5.) Outstanding Advanced Engineering Innovation: The winning nominee is a company that has achieved a significant milestone in advanced engineering - where Technology is used to design a product.

The objective of the Filled Inorganic Resin Films (FIRF) effort is to design, synthesize, and deliver sufficient quantities of filled, non-charring, particulate composites. Following demonstration of two initial test series, progress shall be reviewed. The technology showing significantly enhanced stability over alternative technologies will be pursued via an option phase which shall include technology maturation and risk reduction activities prudent to further identify material performance.

The Biotechnology, Biochemical, and Biomass Engineering (BBBE) program supports fundamental engineering research that advances the understanding of cellular and biomolecular processes (in vivo, in vitro, and/or ex vivo) and eventually leads to the development of enabling technology and/or applications in support of the biopharmaceutical, biotechnology, and bioenergy industries, or with applications in health or the environment.  Quantitative assessments of bioprocesses are considered vital to successful research projects in the BBBE program.  Fundamental to many research projects in this area is the understanding of how biomolecules and cells interact in their environment, and how those molecular level interactions lead to changes in structure, function, phenotype, and/or behavior.  The program encourages proposals that address emerging research areas and technologies that effectively integrate knowledge and practices from different disciplines, and effectively incorporate ongoing research into educational activities. Research projects of particular interest in BBBE include, but are not limited to: Metabolic engineering and synthetic biology Quantitative systems biotechnology Tissue engineering and stem cell culture technologies Protein engineering/protein design Development of novel "omics" tools for biotechnology applications